Â鶹´«Ã½Ó³»­

I am a Syrian-registered pharmacist who completed a Bachelor of Pharmacy degree at the Arab International University in Syria in 2013. Following the receipt of the prestigious Erasmus Mundus Avempace 2 Award from the EU Commission, I began my PhD at the Institute Charles Gerhardt (ICGM) / University of Montpellier, France. My doctoral research, conducted within the Advanced Materials for Health and Catalysis research team, focused on developing novel lipid-based nanoformulations and nanocrystals for the transdermal delivery of antioxidants.

In 2016, I joined the University of Rennes 1, School of Pharmacy, as a Research and Teaching Fellow, where I worked on polymeric nanoparticles for delivering inorganic photosensitizing agents for the theranostic management of ovarian cancer. In May 2018, I joined Queen’s University Belfast School of Pharmacy as a Lecturer in Pharmaceutical Sciences. In 2023, I was promoted to Senior Lecturer, and in April 2025, I joined Â鶹´«Ã½Ó³»­ as a Senior Lecturer in Pharmaceutical Technology, where I lead the pharmaceutics development within the MPharm program.

• Profesiynol: HEA fellowship
  Advance HE, 2020
• Profesiynol: The Postgraduate Certificate in Higher Education Teaching (PGCHET
  Queen's University, Belfast, 2020
• PhD: PhD in pharmaceutical technology: Comparison of topical quercetin nanoformulations for skin protection
  Université de Montpellier, 2016

I teach pharmaceutical sciences and technology components within the MPharm program. Additionally, I engage in pedagogical research aimed at enhancing student engagement and learning through various blended learning approaches. My role extends to administrative responsibilities, including serving as the advisor of studies and others.

My research focuses on developing novel nanomaterials for delivering a broad range of therapeutic agents and fabricating multifunctional nanoparticles to target cancer and other diseases. My long-term goal is to facilitate the translation of nanoparticle-based systems from the lab to the clinic using scalable technologies. I am particularly interested in improving the physiochemical properties of poorly water-soluble drugs to enhance their bioavailability through nanotechnology-based formulations.

My current research themes include:

1. Lipid-based nano-systems for targeted drug delivery to skin tissue

2. Nanocrystals for poorly water-soluble drugs

3. Novel topical therapies for skin cancers and inflammatory skin diseases

• Safer, scalable, and modifiable polymer-based lipid nanocapsules for drug delivery
• Development of antioxidants-based nanoparticles for topical application
• Development of next-generation nanoparticles loaded hydrogels containing multiple active agents for improved treatment of bacterial infections
• Development of anti-inflammatory-based nanoparticles for topical treatment of psoriasis

2026

• Cyhoeddwyd
  Hatahet, T., Alrfooh, O., Ekrayem, Z., Al-Haj Darwish, M., Alomar, R. & Abdin, A., 21 Medi 2026, Yn: Vulnerable Children and Youth Studies. t. 1-19 19 t.
  Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
• Cyhoeddwyd
  Aljabali, A. A. A., Obeid, M. A., Alqudah, A., Hamzat, Y., Alqudah, A., Alzoubi, L., Gammoh, O., Qnais, E., Mishra, V., Mishra, Y., Hatahet, T. & El-Tanani, M., 9 Hyd 2026, Yn: Cancers. 18, 20, 3254.
  Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
• Cyhoeddwyd
  Al Obaidi, H., Jirjees, F. J. & Hatahet, T., 14 Ebr 2026, Handbook of Evidence-Based Pharmacist Care: Clinical, Economic, and Humanistic Impacts . Al-Worafi, Y. (gol.). 1 gol. New York: Taylor and Francis, Cyfrol 1.
  Allbwn ymchwil: Pennod mewn Llyfr/Adroddiad/Trafodion Cynhadledd › Pennod › adolygiad gan gymheiriaid
• E-gyhoeddi cyn argraffu
  Al Khateeb, M., Shawaqfeh, B., Rustom, M., Almounajed, L., Sahloul, L., Mozeh, A. & Hatahet, T., 7 Ebr 2026, (E-gyhoeddi cyn argraffu) Yn: International Journal of Pharmacy Practice. t. 1-11 11 t., riag044.
  Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
• E-gyhoeddi cyn argraffu
  Alotaibi, H., Al Hamod, M., Aljuaid, M., Alnefaie, M. K., Alfuraih, S., Al Hamood, N. & Hatahet, T., 8 Gorff 2026, (E-gyhoeddi cyn argraffu) Yn: Nanomedicine (London, England). 21, 14, t. 2159-2172 14 t.
  Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl adolygu › adolygiad gan gymheiriaid
• Cyhoeddwyd
  Hatahet, T., Alnajar , A., Karam, S., Fael , H., Kayalli, A., Alra'e, A., Alrayes , Z., Zarzor, M. S., JALAL, N. A. & Hatahet, T., 5 Awst 2026, Syrian Science Council.
  Allbwn ymchwil: Cyfraniad at gyhoeddiad arbenigol › Erthygl
• Cyhoeddwyd
  Hatahet, T., Al-Shawa, O., Dadou, S., Karah Hamad, M. & Al-Hafyan, M. R., Ebr 2026, Syrian Science Council.
  Allbwn ymchwil: Cyfraniad at gyhoeddiad arbenigol › Erthygl

2025

• Cyhoeddwyd
  Hatahet, T., Alachkar, A., Al Barakat Almasalma, A. & Abazid, A., Ebr 2025.
  Allbwn ymchwil: Cyfraniad at gynhadledd › Papur › adolygiad gan gymheiriaid
• Cyhoeddwyd
  Al-Jamal, W. T., Reboredo, C., Abdi, U., Curci, P., Qadadeh, R., Alotaibi, H., Casettari, L. & Hatahet, T., 5 Ion 2025, Yn: International Journal of Pharmaceutics. 668
  Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
• E-gyhoeddi cyn argraffu
  Aljabali, A. A. A., Gammoh, O., Obeid, M. A., Qnais, E., Alqudah, A., El-Tanani, M. & Hatahet, T., 11 Gorff 2025, (E-gyhoeddi cyn argraffu) Yn: Current Cancer Drug Targets .
  Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl adolygu › adolygiad gan gymheiriaid
• Cyhoeddwyd
  El-Tanani, M., Satyam, S. M., Rabbani, S. A., Obeidat, R. M., El-Tanani, Y., Aljabali, A. A. A. & Hatahet, T., 31 Maw 2025, Yn: PLoS ONE. 20, 3, t. e0319748
  Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
• Cyhoeddwyd
  Wu, S., Hatahet, T. & Al-Jamal, W., 1 Mai 2025, Yn: European Journal of Pharmaceutical Sciences. 208, 1070409.
  Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
• Cyhoeddwyd
  bani Salameh, R., Al-Smadi, A., Gammoh, O., Shajrawi, A., Ashour, A., Alrfooh, O., Fitzsimons, D., Hatahet, T., Yahia Binsaleh, A. & Abdul Rahim Shilbayeh, S., 7 Awst 2025, Yn: PLoS ONE. 20, 8
  Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl adolygu › adolygiad gan gymheiriaid
• Cyhoeddwyd
  Alomar, R., Hatahet, T. & Younes, M., 20 Mai 2025.
  Allbwn ymchwil: Cyfraniad at gynhadledd › Crynodeb
• Cyhoeddwyd
  Wu, S., Hatahet, T., Bona, B. L., Lodigiani, G., Zhang, M., Baldelli Bombelli, F. & Al-Jamal, W. T., 15 Maw 2025, Yn: International Journal of Pharmaceutics. 672, 125358.
  Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
• Cyhoeddwyd
  Qnais, E., Gammoh, O., Alqudah, M., Al-Bzour, M., Wedyan, M., Alqudah, A., Alnakhli, A. M., Shilbayeh, S. A. R., Aljabali, A. A. A. & Hatahet, T., 29 Tach 2025, Yn: Molecular Neurobiology. 63, 1, 216.
  Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
• Cyhoeddwyd
  Qnais, E., Alqudah, A., Gammoh, O., Bsieso, Y., Wedyan, M., Alotaibi, B. S., Aljabali, A. A. A. & Hatahet, T., 16 Hyd 2025, Yn: Molecular Biology Reports. 52, 1033.
  Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
• Cyhoeddwyd
  Gammoh, O., Qnais, E., Aljabali, A. A. A., Hatahet, T. & Alqudah, A., 5 Meh 2025, Yn: Molecular Biology Reports. 52, t. 1-18 18 t., 550.
  Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl adolygu › adolygiad gan gymheiriaid
• E-gyhoeddi cyn argraffu
  Aljabali, A. A. A., Gammoh, O., Qnais, E., Alqudah, A., El-Tanani, Y., Mishra, V., Mishra, Y., El-Tanani, M. & Hatahet, T., 11 Rhag 2025, (E-gyhoeddi cyn argraffu) Yn: Expert opinion on biological therapy. 25, 12, t. 1313-1331 19 t.
  Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl adolygu › adolygiad gan gymheiriaid
• Cyhoeddwyd
  Aljabali, A. A. A., Alqudah, A., Bashatwah, R. M., Alsharedeh, R., Qnais, E., Gammoh, O., Mishra, V., Mishra, Y., El-Tanani, M. & Hatahet, T., 13 Tach 2025, Yn: Zoonotic Diseases . 5, 4, 35.
  Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl adolygu › adolygiad gan gymheiriaid
• Cyhoeddwyd
  Aljabali, A. A. A., Obeid, M. A., Bashatwah, R. M., Qnais, E., Gammoh, O., Alqudah, A., Mishra, V., Mishra, Y., Khan, M. A., Parvez, S., El-Tanani, M. & Hatahet, T., Awst 2025, Yn: Chemistry & Biodiversity. 22, 8, e202402479.
  Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
• Cyhoeddwyd
  Qnais, E., Gammoh, O., Bsieso, Y., Alqudah, M., Wedyan, M., Altaber, S., Aljabali, A. A. A., Alqudah, A. & Hatahet, T., 1 Chwef 2025, Yn: Phytomedicine Plus.
  Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
• E-gyhoeddi cyn argraffu
  Alotaibi, H., Hatahet, T. & Al-Jamal, W. T., 14 Mai 2025, (E-gyhoeddi cyn argraffu) Yn: European Journal of Pharmaceutics and Biopharmaceutics. 213, 114747.
  Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
• E-gyhoeddi cyn argraffu
  Hatahet, T., 19 Chwef 2025, (E-gyhoeddi cyn argraffu) Yn: Social Sciences & Humanities Open. 11, 101347.
  Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
• Cyhoeddwyd
  Alotaibi, H., Hatahet, T. & Al-Jamal, W. T., 12 Chwef 2025, Yn: European Journal of Pharmaceutical Sciences. 207, 107034.
  Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
• Cyhoeddwyd
  Sweeney, G., Liu, D., Hatahet, T., Jones , D., Li, S. & Andrews, G., 24 Gorff 2025, Yn: Pharmaceutics. 17, 8, 955.
  Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
• Cyhoeddwyd
  Hatahet, T., Dadou, S., Oyoun, F. & Zidan, A., 24 Tach 2025, Syrian Science Council.
  Allbwn ymchwil: Cyfraniad at gyhoeddiad arbenigol › Erthygl
• Cyhoeddwyd
  Bouri, F., Ekrayem, Z., Ekrayem, A., Alomar, R. & Hatahet, T., 7 Awst 2025, Germany: Syrian Science Council (SSC).
  Allbwn ymchwil: Llyfr/Adroddiad › Adoddiad Arall › adolygiad gan gymheiriaid

2024

• E-gyhoeddi cyn argraffu
  Hatahet, T., Ekrayem, Z., Badwi, S., Hardan, S., Abdin, A. E. & Alrfooh, O., 17 Mai 2024, (E-gyhoeddi cyn argraffu) Yn: Vulnerable Children and Youth Studies. 19, 3, t. 1-18 18 t.
  Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
• Cyhoeddwyd
  Alotaibi, H., Hatahet, T. & Al-Jamal, W. T., 15 Awst 2024, Yn: International Journal of Pharmaceutics. 661
  Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
• Cyhoeddwyd
  Hatahet, T., Mohamed, A. A. R., Malekigorji, M., Clerkin, C. & Sandrey, L., 1 Meh 2024, Yn: Advances in Online Education. 2, 4, t. 330-350 21 t.
  Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
• Cyhoeddwyd
  Alqudah, A., Qnais, E., Gammoh, O., Bseiso, Y., Wedyan, M., Alqudah, M., Oqal, M., Abudalo, R. & Hatahet, T., 18 Meh 2024, Yn: Psychopharmacology.
  Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

2023

• Cyhoeddwyd
  Hatahet, T., Alkhaledi, A., Tello, A., Jarad, L., Al Shihabi, A. & Campbell, K., 20 Medi 2023, Yn: Educational Research and Evaluation: An International Journal on Theory and Practice. 28, 1-3, t. 42-59 18 t.
  Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
• Cyhoeddwyd
  Alotaibi, H., Hatahet, T. & Al-Jamal, W., 22 Meh 2023.
  Allbwn ymchwil: Cyfraniad at gynhadledd › Papur
• Cyhoeddwyd
  Wu, S., Hatahet, T. & Al-Jamal, W., 1 Meh 2023.
  Allbwn ymchwil: Cyfraniad at gynhadledd › Papur

2022

• Cyhoeddwyd
  Alzubaidi, H., Jirjees, F. J., Franson, K. L., Saidawi, W., Othman, A. M., Rabeeah, Z. H., Al Obaidi, H., Hatahet, T. & Caliph, S., 5 Hyd 2022, Yn: International Journal of Pharmacy Practice. 29, 6
  Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
• Cyhoeddwyd
  Clerkin, C., Hatahet, T., Malekigorji, M. & Andrews, G. P., 28 Hyd 2022, Yn: Education Sciences. 12, 11, 761.
  Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
• Cyhoeddwyd
  Alotaibi, H., Hatahet, T. & Al-Jamal, W., 23 Awst 2022.
  Allbwn ymchwil: Cyfraniad at gynhadledd › Papur
• Cyhoeddwyd
  Alotaibi, H., Hatahet, T. & Al-Jamal, W., 7 Medi 2022.
  Allbwn ymchwil: Cyfraniad at gynhadledd › Papur
• Cyhoeddwyd
  Hatahet, T., Wu, S., Yang, H. & Al-Jamal, W., 7 Medi 2022.
  Allbwn ymchwil: Cyfraniad at gynhadledd › Papur
• Cyhoeddwyd
  Wu, S., Hatahet, T. & Al-Jamal, W., 9 Medi 2022.
  Allbwn ymchwil: Cyfraniad at gynhadledd › Papur
• Cyhoeddwyd
  Hatahet, T., Mohamed, A. A. R., Malekigorji, M. & Kerry, E., 6 Ebr 2022.
  Allbwn ymchwil: Cyfraniad at gynhadledd › Papur
• Cyhoeddwyd
  Hatahet, T., Mohamed, A. A. R., Malekigorji, M. & Kerry, E., 1 Chwef 2022, Yn: Pharmacy. 10, 1
  Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
• Cyhoeddwyd
  Sahloul, L., Bouri, F., Bsso, E., Saleh, A., Darwish , E., Yaseen, L., Muhamed Mustafa, A. & Hatahet, T., 27 Medi 2022, Yn: Journal of Pharmaceutical Health Services Research. t. 364-369 13.
  Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
• Cyhoeddwyd
  Hatahet, T., Al Obaidi, H., Tekko, I. A. & Chen, T., 1 Medi 2022, Yn: Saudi Pharmaceutical Journal. 30, 9, t. 1283-1292
  Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

2021

• Cyhoeddwyd
  Jirjees, F. J., Saad, A. K., Al Hano, Z., Hatahet, T., Al Obaidi, H. & Dallal Bashi, Y. H., 1 Ebr 2021, Yn: Infectious Disease Reports. 13, 2
  Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

2020

• Cyhoeddwyd
  Malekigorji, M. & Hatahet, T., 24 Hyd 2020, Yn: Pharmacy. 8, 4
  Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
• Cyhoeddwyd
  Tekko, I. A., Permana , A. D., Vora , L., Hatahet, T., McCarthy , H. O. & Donnelly , R. F., 1 Medi 2020, Yn: European Journal of Pharmaceutical Sciences. 152, 105469.
  Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

2019

• Cyhoeddwyd
  Malekigorji, M. & Hatahet, T., 2019.
  Allbwn ymchwil: Cyfraniad at gynhadledd › Papur
• Cyhoeddwyd
  Malekigorji, M. & Hatahet, T., 2019.
  Allbwn ymchwil: Cyfraniad at gynhadledd › Murlen
• Cyhoeddwyd
  Hatahet, T. & Malekigorji, M., 2019.
  Allbwn ymchwil: Cyfraniad at gynhadledd › Papur
• Cyhoeddwyd
  Tekko, I. A., Ali, O. M., Hatahet, T. & Chehna, M. F., 7 Tach 2019, Yn: Archives of Pharmacy & Pharmacology Research. 2, 3
  Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

2018

• Cyhoeddwyd
  Hatahet, T., Morille, M., Hommoss, A., Devoisselle, J. M., Muller , R. & Begu, S., 5 Mai 2018, Yn: International Journal of Pharmaceutics. 542, 1-2, t. 176-185
  Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
• Cyhoeddwyd
  Hatahet, T., Brandhonneura, N., Amela-Cortes, M., Molard, Y., Cordier, S. & Dolloa, G., 1 Ebr 2018, Yn: European Journal of Pharmaceutics and Biopharmaceutics. 125, t. 95-105
  Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

2017

• Cyhoeddwyd
  Hatahet, T., Morille, M., Shamseddin, A., Aubert-Pouëssel, A., Devoisselle, J. M. & Begu, S., 25 Chwef 2017, Yn: International Journal of Pharmaceutics. 518, 1-2
  Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

2016

• Cyhoeddwyd
  Hatahet, T., Morille, M., Hommoss, A., Dorandeu, C., Muller , R. & Begu, S., 1 Mai 2016, Yn: European Journal of Pharmaceutics and Biopharmaceutics. 102, t. 51-63
  Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
• Cyhoeddwyd
  Hatahet, T., Morille, M., Hommoss, A., Devoisselle, J. M., Muller , R. & Begu, S., 1 Tach 2016, Yn: European Journal of Pharmaceutics and Biopharmaceutics. 108, t. 41-53
  Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

2026

• 10 Hyd 2026 – 11 Hyd 2026

  Cysylltau:

  Gweithgaredd: Sgwrs wadd (Siaradwr)

• The first year of Syria's post-Assad transition confronted educators with a paradox that policy alone cannot resolve: schools can be reopened before the conditions that make teaching meaningful are restored. Infrastructure is visible and measurable; the professional confidence, relational trust, and pedagogical capacity of teachers are not. This paper argues that educational recovery in transitional Syria requires attending as seriously to these invisible conditions as to buildings and curricula — and that practitioner-led initiatives are currently the primary site where this work is happening.

  Drawing on programme data from the Abjad Initiative's Iqra Programme (2025–2026) — which reached 1,553 students and 60 educators across four schools in Idlib and Rural Damascus — we examine what an integrated intervention model looks like in practice and what it produces. The programme combined school rehabilitation, structured teacher capacity building across three specialist modules (remedial education, literacy and numeracy, and non-violent classroom management, totalling 40 training hours per school), and Social-Emotional Learning frameworks for students. We use Priestley, Biesta and Robinson's (2015) ecological model of teacher agency as an analytical lens, arguing that capacity building in post-conflict contexts only produces durable change when it simultaneously addresses the material, institutional, and relational conditions within which teachers work — not professional skills in isolation.

  Pre- and post-assessment data show significant gains: teacher competencies improved by 72–91% across modules in Idlib, and student academic scores rose from 44.31 to 83 on the Tigla assessment in Rural Damascus — a gain of +38.69 within approximately four months. But the most telling evidence comes from outside the programme itself. A follow-up study tracking former Abjad students after their transition to new schools found that teachers in receiving schools — without being told which students had participated in the programme — consistently identified them as different: more cooperative, more attentive, better able to understand others and express themselves. This transfer of learning dispositions across educational environments suggests that the programme's impact reached beyond measurable skills into something harder to name but easier to recognise: children who had been taught as if their learning and wellbeing mattered.

  This paper is situated within a broader research agenda examining teacher agency and recognition in Syria's contested educational landscapes, and reflects on what practitioner-led programme evidence can contribute to that inquiry. It concludes by examining what these findings reveal about the gap between emergency education and genuine educational recovery, and what practitioner-led models can offer Syria's longer-term educational reconstruction at a moment when state-level policy reform remains nascent.

  17 Medi 2026 – 18 Medi 2026

  Gweithgaredd: Cyflwyniad llafar (Siaradwr)

• Transnational Education (TNE) Collaboration Visit: Dr. Yomna Moussa (The British University in Egypt)

  As part of the British Council-funded project, "Sustainability in pharmacy teaching and practice: a bridge towards TNE cooperation," Â鶹´«Ã½Ó³»­'s North Wales Medical School hosted Dr. Yomna Moussa from The British University in Egypt (BUE) to advance collaborative initiatives in pharmacy education and research.

  The multi-day visit focused on integrating advanced pedagogical technologies, embedding sustainability into practice, and scoping future structural partnerships between the two institutions:

  Digital & Immersive Learning Integration: The team explored the incorporation of digital learning solutions like LearnSci within Bangor's simulated pharmacy ("Fferyllfa") to build contextualized quantitative skills. Additionally, the visit featured an evaluation of a VR aseptic manufacturing simulation—in collaboration with Azize Naji (CEO, Goggleminds) and Chris Goodwin (Senior QC Analyst, Betsi Cadwaladr UHB)—to plan its dual deployment in the BU and BUE curricula.

  Sustainable Research Infrastructure: Alongside Dr. Sherif Hamdallah and Prof. Stephen Doughty (Head of NWMS), the delegation toured Bangor's research and teaching facilities, focusing on actionable ways to embed sustainability at the core of joint pharmaceutical science research.

  TNE Programme Expansion: Foundational discussions were held with Joanna Edwards (NWMS Director of Teaching and Learning) regarding further curriculum alignment. This serves as an exploratory seed for developing a comprehensive, long-term TNE degree partnership.

  Future Grant Strategy: The visit concluded with strategic planning to secure further funding, specifically scoping two additional grant applications to strengthen cross-border cooperation and expand joint sustainability initiatives.

  24 Awst 2026 – 27 Awst 2026

  Gweithgaredd: Gwesteio ymwelydd academaidd (Gwesteiwr)

• 8 Meh 2026 – 9 Meh 2026

  Cysylltau:

  Gweithgaredd: Sgwrs wadd (Siaradwr)

• Pharmacist’s pivotal role in health awareness, prevention, and the rational use of medicines. We emphasized the importance of aligning academic research with real-world community needs to provide tangible solutions for the healthcare system.

  15 Ebr 2026

  Cysylltau:

  Gweithgaredd: Cyflwyniad llafar (Siaradwr)

• 20 Maw 2026

  Gweithgaredd: Cyflwyniad llafar (Siaradwr)

2025

• 20 Rhag 2025

  Cysylltau:

  Gweithgaredd: Cymryd rhan mewn cynhadledd Academaidd (Trefnydd)